Figure 3.

Effects of rosiglitazone and T0070907 on the adhesive and proliferative capabilities of VECs. VECs were treated with the PPARγ agonist rosiglitazone and the antagonist T0070907. NC cells were treated with dimethyl sulfoxide. Cellular impedance assays were used to evaluate VEC (A) adhesion and (B) proliferation. Data are presented as the mean ± standard error of at least 3 independent experiments. *P<0.05, **P<0.01 vs. NC. VEC, vascular endothelial cell; PPAR, peroxisome proliferator-activated receptor; NC, negative control; R, rosiglitazone; T, T0070907.